Detalhe da pesquisa
1.
Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database.
BMC Med
; 22(1): 65, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355513